Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
64.97 USD | +0.02% | -.--% | +240.87% |
Financials (USD)
Sales 2022 | 30.06M | Sales 2023 | 58.88M | Capitalization | 1.11B |
---|---|---|---|---|---|
Net income 2022 | -57M | Net income 2023 | -32M | EV / Sales 2022 | 3.79 x |
Net cash position 2022 | 223M | Net cash position 2023 | 317M | EV / Sales 2023 | 13.4 x |
P/E ratio 2022 |
-4.25
x | P/E ratio 2023 |
-29.6
x | Employees | 142 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 96.04% |
Latest transcript on Alpine Immune Sciences, Inc.
1 day | +0.02% | ||
1 month | +0.23% | ||
3 months | +80.82% | ||
6 months | +285.81% | ||
Current year | +240.87% |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.64% | 4 M€ | -5.15% | - | |
0.02% | 0 M€ | 0.00% | - | |
0.01% | 0 M€ | 0.00% | - | |
0.00% | 9 M€ | +9.79% | - |
1st Jan change | Capi. | |
---|---|---|
+240.87% | 4.46B | |
+18.77% | 125B | |
+14.05% | 108B | |
-7.16% | 24.21B | |
+2.07% | 22.78B | |
-10.79% | 17.96B | |
-41.74% | 16.43B | |
-13.47% | 16.37B | |
+2.23% | 13.58B | |
+27.13% | 11.66B |
- Stock Market
- Equities
- ALPN Stock